Quest to Outfit Labs With Bio-Rad's BioPlex 2200 Platform, HIV Assay | GenomeWeb
NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it will supply Quest Diagnostics with its BioPlex 2200 systems and autoimmune test reagents, as well as its HIV-1/HIV-2 PLUS O EIA assay for use in its reference laboratories nationwide.
Terms of the agreements were not released.
In early April Bio-Rad announced that it had released Epstein Barr virus kits to run on the BioPlex 2200 system and that it has more than 15 other multiplex reagent kits in development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.